Mono Propylene Glycol (E1520) CAS: 57-55-6
Related Insights
PCS Singapore Force Majeure Wind-Down Status: What the Latest Market Developments Mean for Petrochemical Buyers
Recent geopolitical developments have renewed attention on PCS Singapore's force majeure position and its implications for regional petrochemical supply. Buyers of polyethylene, polypropylene and ethylene derivatives should reassess supplier communication and supply chain contingency plans.
Strait of Hormuz Supply Risk: What Chemical Buyers Should Do Amid Iran Talks Uncertainty
Conflicting statements about Iran negotiations create uncertainty for global chemical procurement teams. The latest Strait of Hormuz supply signals show why buyers should rely on verified logistics data instead of political headlines.
Chemical Procurement Risks After Gulf Ship Attacks: What Buyers Need to Know in 2026
Chemical procurement teams are facing a new supply chain challenge as Gulf shipping risks increase while energy and commodity flows recover. This analysis explains how recent ship attacks could influence chemical sourcing, freight planning and supplier strategies.
Guar Gum: Rajasthan Planting Intelligence and Implications for the 2026/27 Supply Season
The 2026 Rajasthan guar planting season will determine global guar gum availability for oilfield, food and industrial buyers over the coming year. Early monsoon progress has improved market sentiment, but rainfall distribution across key producing districts will decide whether procurement teams face abundant supply or tighter inventories.
Pharmaceutical Chemical Procurement Intelligence: June 24, 2026 Situation Report
Pharmaceutical procurement teams face an unusually complex H2 2026 environment shaped by GLP-1 manufacturing demand, excipient compliance changes, freight cost shifts, regulatory deadlines, and elevated drug shortage risk across critical therapeutic categories.
Pharma Solvent Markets: DMF, Acetonitrile, and IPA as GLP-1 Production Ramps Up
DMF, acetonitrile, and IPA markets are entering a new demand cycle as GLP-1 API production scales globally. Pharmaceutical buyers should renegotiate solvent contracts now before rising peptide manufacturing demand tightens supply in H2 2026
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.
